These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 30608575)

  • 1. Beta-blocker, aspirin, and statin usage after first-time myocardial infarction in patients with chronic obstructive pulmonary disease: a nationwide analysis from 1995 to 2015 in Denmark.
    Rasmussen DB; Bodtger U; Lamberts M; Nicolaisen SK; Sessa M; Capuano A; Torp-Pedersen C; Gislason G; Lange P; Jensen MT
    Eur Heart J Qual Care Clin Outcomes; 2020 Jan; 6(1):23-31. PubMed ID: 30608575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medication in relation to ST-segment elevation myocardial infarction in patients with a first myocardial infarction: Swedish Register of Information and Knowledge About Swedish Heart Intensive Care Admissions (RIKS-HIA).
    Björck L; Wallentin L; Stenestrand U; Lappas G; Rosengren A
    Arch Intern Med; 2010 Aug; 170(15):1375-81. PubMed ID: 20696964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta-blocker use and acute exacerbations of COPD following myocardial infarction: a Danish nationwide cohort study.
    Rasmussen DB; Bodtger U; Lamberts M; Torp-Pedersen C; Gislason G; Lange P; Jensen MT
    Thorax; 2020 Nov; 75(11):928-933. PubMed ID: 32820080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mortality associated with cardiovascular drugs in patients with chronic obstructive pulmonary disease and right-sided heart failure - A danish nationwide registry-based study.
    Andersson C; Hansen PW; Steffensen IE; Andreasen C; Weeke PE; Køber L; Gislason GH; Torp-Pedersen C
    Eur J Intern Med; 2019 May; 63():56-61. PubMed ID: 30833208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Underuse of beta-blockers by patients with COPD and co-morbid acute coronary syndrome: A nationwide follow-up study in New Zealand.
    Parkin L; Quon J; Sharples K; Barson D; Dummer J
    Respirology; 2020 Feb; 25(2):173-182. PubMed ID: 31401813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Temporal Trends in Treatment and Outcomes of Acute Myocardial Infarction in Patients With Chronic Obstructive Pulmonary Disease: A Nationwide Population-Based Observational Study.
    Su TH; Chang SH; Chen PC; Chan YL
    J Am Heart Assoc; 2017 Mar; 6(3):. PubMed ID: 28298371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short- and Long-term Myocardial Infarction Survival Rate According to the Type of Drugs Prescribed at the Time of Discharge: A Study Using Iran National Registry Data.
    Mozaffarian S; Taherpour N; Sistanizad M; Aghaali M; Hashemi Nazari SS
    Arch Iran Med; 2022 Feb; 25(2):105-111. PubMed ID: 35429947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-Term Quality of Prescription for ST-Segment Elevation Myocardial Infarction (STEMI) Patients: A Real World 1-Year Follow-Up Study.
    Bruggmann C; Iglesias JF; Gex-Fabry M; Fesselet R; Vogt P; Sadeghipour F; Voirol P
    Am J Cardiovasc Drugs; 2020 Feb; 20(1):105-115. PubMed ID: 31300969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. β-blocker use and mortality in COPD patients after myocardial infarction: a Swedish nationwide observational study.
    Andell P; Erlinge D; Smith JG; Sundström J; Lindahl B; James S; Koul S
    J Am Heart Assoc; 2015 Apr; 4(4):. PubMed ID: 25854796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decade-Long Trends (2001 to 2011) in the Use of Evidence-Based Medical Therapies at the Time of Hospital Discharge for Patients Surviving Acute Myocardial Infarction.
    Makam RC; Erskine N; McManus DD; Lessard D; Gore JM; Yarzebski J; Goldberg RJ
    Am J Cardiol; 2016 Dec; 118(12):1792-1797. PubMed ID: 27743577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improving outcomes in chronic obstructive pulmonary disease by taking beta-blockers after acute myocardial infarction: a nationwide observational study.
    Wang WH; Cheng CC; Mar GY; Wei KC; Huang WC; Liu CP
    Heart Vessels; 2019 Jul; 34(7):1158-1167. PubMed ID: 30680495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of β blockers on mortality after myocardial infarction in adults with COPD: population based cohort study of UK electronic healthcare records.
    Quint JK; Herrett E; Bhaskaran K; Timmis A; Hemingway H; Wedzicha JA; Smeeth L
    BMJ; 2013 Nov; 347():f6650. PubMed ID: 24270505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of chronic obstructive pulmonary disease on in-hospital morbidity and mortality in patients with ST-segment elevation myocardial infarction treated by primary percutaneous coronary intervention.
    Șerban RC; Hadadi L; Șuș I; Lakatos EK; Demjen Z; Scridon A
    Int J Cardiol; 2017 Sep; 243():437-442. PubMed ID: 28506549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in the mode of presentation for acute coronary syndrome by pre-hospitalization medication, in relation to coronary risk factors, East-Osaka acute coronary syndrome (EACS) registry.
    Hoshida S; Yuasa F; Lim YJ; Kijima Y; Iwasaka J; Iwasaka T;
    Atherosclerosis; 2011 Nov; 219(1):355-60. PubMed ID: 21851942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A combination of statins and beta-blockers is independently associated with a reduction in the incidence of perioperative mortality and nonfatal myocardial infarction in patients undergoing abdominal aortic aneurysm surgery.
    Kertai MD; Boersma E; Westerhout CM; Klein J; Van Urk H; Bax JJ; Roelandt JR; Poldermans D
    Eur J Vasc Endovasc Surg; 2004 Oct; 28(4):343-52. PubMed ID: 15350554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. β-blockers after acute myocardial infarction in patients with chronic obstructive pulmonary disease: A nationwide population-based observational study.
    Su TH; Chang SH; Kuo CF; Liu PH; Chan YL
    PLoS One; 2019; 14(3):e0213187. PubMed ID: 30835781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. β-Blocker Use and Clinical Outcomes in Patients With COPD Following Acute Myocardial Infarction.
    LaFon DC; Helgeson ES; Lindberg S; Voelker H; Bhatt SP; Casaburi R; Cassady SJ; Connett J; Criner GJ; Hatipoglu U; Kaminsky DA; Kunisaki KM; Lazarus SC; McEvoy CE; Reed RM; Sciurba FC; Stringer W; Dransfield MT
    JAMA Netw Open; 2024 May; 7(5):e247535. PubMed ID: 38771577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secondary medical prevention among Danish patients hospitalised with either peripheral arterial disease or myocardial infarction.
    Gasse C; Jacobsen J; Larsen AC; Schmidt EB; Johannesen NL; Videbaek J; Sørensen HT; Johnsen SP
    Eur J Vasc Endovasc Surg; 2008 Jan; 35(1):51-8. PubMed ID: 17923426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimal secondary prevention medication use in acute myocardial infarction patients with nonobstructive coronary artery disease is modified by management strategy: insights from the TRIUMPH Registry.
    Pitts R; Daugherty SL; Tang F; Jones P; Ho PM; Tsai TT; Spertus J; Maddox TM
    Clin Cardiol; 2017 Jun; 40(6):347-355. PubMed ID: 28387960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Initiation and adherence to secondary prevention pharmacotherapy after myocardial infarction in patients with rheumatoid arthritis: a nationwide cohort study.
    Lindhardsen J; Ahlehoff O; Gislason GH; Madsen OR; Olesen JB; Torp-Pedersen C; Hansen PR
    Ann Rheum Dis; 2012 Sep; 71(9):1496-501. PubMed ID: 22402144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.